CorMedix CRMD
NASDAQ CRMD
$7.76 +0.18 (+2.44%)
As of: Oct 21, 2026 · 11:41 AM EDT

CorMedix (CRMD) Current Leases (2025)

Updated

CorMedix (CRMD) recorded Current Leases of $596,000 in Q4 2025, up 2.9% from the prior quarter.

Analysis

CorMedix (CRMD) Current Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 CorMedix 608.33 Mn -44.19 Mn 77.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 596,000.00
Sep 30, 2025 579,168.00
API Access

CorMedix Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CRMD&period=max&api_key=YOUR_API_KEY